Cited by 513COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory Support and Mechanisms

The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Open access

Sun, Xinjuan, Wang, Tianyuan, Cai, Dayong, Hu, Zhiwei, Chen, Jin’an, Liao, Hui, Zhi, Liming, Wei, Hongxia, Zhang, Zhihong, Qiu, Yuying, Wang, Jing, Wang, Aiping·2020·Cytokine & Growth Factor Reviews

DOI 10.1016/j.cytogfr.2020.04.002PMC PMC7182527

Open this paper in CoChat — free account Open PDF

Abstract

Clinical intervention in patients with corona virus disease 2019 (COVID-19) has demonstrated a strong upregulation of cytokine production in patients who are critically ill with SARS-CoV2-induced pneumonia. In a retrospective study of 41 patients with COVID-19, most patients with SARS-CoV-2 infection developed mild symptoms, whereas some patients later developed aggravated disease symptoms, and eventually passed away because of multiple organ dysfunction syndrome (MODS), as a consequence of a severe cytokine storm. Guidelines for the diagnosis and treatment of SARS-CoV-2 infected pneumonia were first published January 30th, 2020; these guidelines recommended for the first time that cytokine monitoring should be applied in severely ill patients to reduce pneumonia related mortality. The cytokine storm observed in COVID-19 illness is also an important component of mortality in other viral diseases, including SARS, MERS and influenza. In view of the severe morbidity and mortality of COVID-19 pneumonia, we review the current understanding of treatment of human coronavirus infections from the perspective of a dysregulated cytokine and immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cytogfr.2020.04.002

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Jin, Y., Cai, L., Cheng, Z., Cheng, H., Deng, T., Fan, Y., Fang, C., Huang, D., Huang, L., Huang, Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,306
Cytokine release syndrome
Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,712
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,428

Show all 36 references

Research works printed but not linked: 3

Tian, 2020, Pulmonary pathology of early phase SARS-COV-2 pneumonia, Preprints
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 · DOI · Paper page
Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 10.1016/S2213-2600(20)30076-X · DOI · Paper page

Sorted by citations

Items 201–300 of 512

CeO2 nanoparticles and cerium species as antiviral agents: Critical review
Shcherbakov, A. B. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100141 · Cited by 13
Comparing COVID-19 and Influenza Presentation and Trajectory
Benaim, A. R., Sobel, J., Almog, R., Lugassy, S., Ben-Shabat, T., Johnson, A. E. W., Eytan, D., & Behar, J. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.656405 · Cited by 13
Guillain‑Barré syndrome associated with Covid‑19: A close relationship or just a coincidence? (Review)
Stoian, A., Bălașa, R., Grigorescu, B. L., Maier, S., Andone, S. R., Cocuz, I. G., Bajkó, Z., Filep, R. C., & Stoian, M. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10348 · Cited by 13
Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
Koch-Heier, J., Schönsiegel, A., Waidele, L. M., Volk, J., Füll, Y., Wallasch, C., Canisius, S., Burnet, M. W. M., & Planz, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893635 · Cited by 13
Dynamic Changes in Circulatory Cytokines and Chemokines Levels in Mild to Severe COVID-19 Patients
Tiwari, V., Agarwal, J., Pathak, A. K., & Singh, S. (2023) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01108-x · Cited by 13
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups
Abdulla, Z. A., Al-Bashir, S. M., Alzoubi, H., Al-Salih, N. S., Aldamen, A. A., & Abdulazeez, A. Z. (2023) · Pathogens · doi:10.3390/pathogens12020329 · Cited by 13
Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases
Gulati, N., Chellappan, D. K., MacLoughlin, R. J., Gupta, G., Singh, S. K., Oliver, B. G. G., Dua, K., & Dureja, H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02882-y · Cited by 13
From ACE2 to COVID-19: A multiorgan endothelial disease
Stein, R. A., & Young, L. M. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.083 · Cited by 14
Análisis del comportamiento de variables ambientales y sociales como factores de riesgo en la propagación del nuevo coronavirus (SARS-CoV-2): caso de estudio en el Perú
Badillo-Rivera, E., Fow, A., Alata-López, F. E., Virú-Vásquez, P., & Acuña, M. S. M. (2021) · Investigaciones Geográficas Boletín del Instituto de Geografía · doi:10.14350/rig.60187 · Cited by 13
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
Tang, W., Chang, Y.-H., Lin, C.-C., Jheng, J.-R., Hsieh, C.-F., Chin, Y., Chang, T.-Y., Lee, J., Liang, P., Lin, C.-Y., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00956-23 · Cited by 12
Discovery of Novel MyD88 Inhibitor A5S to Alleviate Acute Lung Injury with Favorable Drug-like Properties
Chen, P., Zou, Y., Wang, X., Chen, Z., Dong, K., Yang, J., Cui, Y., Gu, J., Wu, X., Li, X., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02401 · Cited by 12
A Comparative Assessment of Effects of Major Mediators of Acute Phase Response (IL-1, TNF-α, IL-6) on Breathing Pattern and Survival Rate in Rats with Acute Progressive Hypoxia
Donina, Z. A., Баранова, Е. В., & Aleksandrova, N. P. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021040177 · Cited by 12
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
Tai, W., Chow, M. Y. T., Chang, R. Y. K., Tang, P., Gonda, I., MacArthur, R. B., Chan, H., & Kwok, P. C. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081260 · Cited by 12
Does IL-6 level help in assessment of severity in COVID-19 Pneumonia, and predicting radiological outcome? Tertiary care center experience of 1000 COVID-19 cases in India
Patil, S. V., Acharya, A., & Gondhali, G. (2022) · The Journal of Medical Research · doi:10.31254/jmr.2022.8207 · Cited by 12
Therapeutics for the Management of Cytokine Release Syndrome in COVID-19
Bhaskar, R., Sinha, J. K., Ghosh, S., Durgvanshi, S., & Han, S. S. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220707114121 · Cited by 11
Efficient selective adsorption of cytokine IL-6 and other middle-macromolecular toxins in the serum of uremia patients with specially designed porous hollow carbon spheres
Zhao, X., Wang, C., Xu, B., Liang, J., Li, K., Guo, Y., Gong, M., Zhao, Y., Huang, Y., Li, Y., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140213 · Cited by 12
Alteration in Redox Status and Lipoprotein Profile in COVID‐19 Patients with Mild, Moderate, and Severe Pneumonia
Lalosevic, M., Kotur‐Stevuljević, J., Vekić, J., Rizzo, M., Kosanović, T., Perović-Blagojević, I., Zeljković, A., Jeremić, D., Mihajlović, M., Petković, A., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8067857 · Cited by 12
Linear regression model and least square method for experimental identification of AMBU bag in simple ventilator
Truong, C. T., Huynh, K. H., Duong, V. T., Nguyen, H. H., Pham, L. A., & Nguyen, T. T. (2022) · International Journal of Intelligent Unmanned Systems · doi:10.1108/ijius-07-2021-0072 · Cited by 13
Dual threat: Susceptibility mechanisms and treatment strategies for COVID-19 and bacterial co-infections
Chen, K., Weng, R., Li, J., Wu, H., Tie, X., Li, H., & Zhang, Y. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.033 · Cited by 10
The neuropathological impact of COVID-19: a review
Fouad, G. I. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-020-00478-7 · Cited by 11
High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.2 · Cited by 11
Th1 cytokine endotype discriminates and predicts severe complications in COVID-19
Hasegawa, T., Hato, T., Okayama, T., Ikeo, K., Miyamoto, Y., Iwanaga, N., Suzuki, K., Yoshida, M., Yamashita, K., Yamashita, S., et al. (2022) · European Cytokine Network · doi:10.1684/ecn.2022.0477 · Cited by 11
Can the hyperthermia‐mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS‐CoV‐2 infection?
Rébé, C., Ghiringhelli, F., & Garrido, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15343 · Cited by 11
Can SARS‐CoV‐2 infection trigger rheumatoid arthritis? A case report
Bouzid, S., Abdelghani, K. B., Miledi, S., Fazaa, A., & Laatar, A. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5748 · Cited by 11
Healing Field: Using Alternating Electric Fields to Prevent Cytokine Storm by Suppressing Clonal Expansion of the Activated Lymphocytes in the Blood Sample of the COVID-19 Patients
Abadijoo, H., Khayamian, M. A., Faramarzpour, M., Ghaderinia, M., Simaee, H., Shalileh, S., Yazdanparast, S. M., Ghabraie, B., Makarem, J., Sarrami‐Forooshani, R., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.850571 · Cited by 11
Effects of Tocilizumab in Critically Ill Patients With COVID-19: A Quasi-Experimental StudyPreprint
de Carvalho, V. C. P., Turon, R., Gonçalves, B., Ceotto, V. F., Kurtz, P., & Righy, C. (2020) · medRxiv · doi:10.1101/2020.07.13.20149328 · Cited by 11
Self-adaptive biomaterials for tissue repair: from design to application
Zheng, W., Jin, Z., Chen, X., Wang, Q., Kang, Y., Chang, J., Peng, P., Wang, B., & Gao, C. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101593 · Cited by 12
COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
Viana, M. D. B., Rosário, B. D. A., de Nazaré, M. D. F. S., Estadella, D., Ribeiro, D. A., & Viana, G. S. D. B. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0074 · Cited by 10
Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
Farooq, M., Khan, A. W., Ahmad, B., Kim, M. S., & Choi, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.915565 · Cited by 10
Nintedanib as an Antifibrotic in Post Covid Lung Fibrosis: Are we Really Overestimating?
Patil, S. V., Tandel, N., Bhangdiya, O., & Gondhali, G. (2023) · SAR Journal of Medicine · doi:10.36346/sarjm.2023.v04i02.001 · Cited by 10
Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19
Zhao, F., Zhang, K., Chen, H., Zhang, T., Zhao, J., Lv, Q., Yu, Q., Ruan, M., Cui, R., & Li, B. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01380-0 · Cited by 11
Role of interleukin-6 in COVID-19 pneumonia as marker of cytokine storm and predictor of course during hospitalization: Prospective, observational study in tertiary care setting in India
Patil, S. V., Dhumal, U., & Acharya, A. (2023) · Annals of Medical Science and Research · doi:10.4103/amsr.amsr_3_23 · Cited by 10
Diabetes mellitus and COVID-19 in the post-acute phase patients - possible links with physical and rehabilitation medicine and balneotherapy
Munteanu, C., Paun, D., ȘUȚĂ, A.-M., Florescu, S. A., & Onose, G. (2020) · Balneo Research Journal · doi:10.12680/balneo.2020.363 · Cited by 9
Progress in Research on SARS-CoV-2 Infection Causing Neurological Diseases and Its Infection Mechanism
Wang, L., Ren, Z., Ma, L., Han, Y., Wei, W., Jiang, E., & Ji, X.-Y. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.592888 · Cited by 10
Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19
Saghazadeh, A., & Rezaei, N. (2021) · Emergent Materials · doi:10.1007/s42247-021-00192-8 · Cited by 10
COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies
Haybar, H., Maniati, M., Saki, N., & Zayeri, Z. D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06333-w · Cited by 11
The interplay between the immune system and SARS-CoV-2 in COVID-19 patients
Shabbir, S., Raza, M. H., Arshad, M., & Khan, M. J. (2021) · Archives of Virology · doi:10.1007/s00705-021-05091-1 · Cited by 11
Burden of cytokines storm on prognosis of SARS-CoV-2 infection through immune response: dynamic analysis and optimal control with immunomodulatory therapy
Rana, P., Chauhan, S., & Mubayi, A. (2022) · The European Physical Journal Special Topics · doi:10.1140/epjs/s11734-022-00435-7 · Cited by 10
Oxidative stress indexes as biomarkers of the severity in COVID-19 patients
Liu, X., Chen, R., Li, B., Zhang, J., Liu, P., Li, B., Li, F., Zhang, W., Lyu, X., & Hu, M. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.102879 · Cited by 9
Respiratory Epithelial Cells Respond to Lactobacillus plantarum but Provide No Cross-Protection against Virus-Induced Inflammation
Mai, E., Percopo, C. M., Limkar, A. R., Sek, A. C., Ma, M., & Rosenberg, H. F. (2020) · Viruses · doi:10.3390/v13010002 · Cited by 9
COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota
Bókkon, I., Kapócs, G., Vucskits, A. V., Erdöfi-Szabó, A., Vagedes, J., Scholkmann, F., & Szőke, H. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210526100147 · Cited by 9
Predicting mortality in critically ill patients with COVID-19 in the ICU from a secondary-level hospital in Ecuador
Vélez-Páez, J. L., Montalvo-Villagómez, M., González, F. E. J., Moscoso, S. X. A., Tercero-Martínez, W., Saltos, L. S., Jiménez-Alulima, G., Irigoyen-Mogro, E., Castro-Reyes, E. E., Mora-Coello, C., et al. (2022) · Bionatura · doi:10.21931/rb/2022.07.01.1 · Cited by 10
Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
Changaripour, S., Sarvazad, H., Barghi, M., Sajadi, E., Sadeghian, M. H., & Roozbahani, N. E. (2022) · Journal of International Medical Research · doi:10.1177/03000605221078699 · Cited by 10
Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice
Ceballo, Y., López, A., González, C. E., Ramos, O., Andújar, I., Martínez, R. U., & Hernández, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07402-4 · Cited by 9
Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic
Mazza, A., Giorgio, A. D., Martelli, L., Pelliccia, C., Pinotti, M. A., Quadri, V., Verdoni, L., Decio, A., Ruggeri, M., & D’Antiga, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.629040 · Cited by 9
COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions
Arjmand, B., Alavi-Moghadam, S., Roudsari, P. P., Rezaei–Tavirani, M., Rahim, F., Gilany, K., Mohamadi-Jahani, F., Adibi, H., & Larijani, B. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.675310 · Cited by 9
Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm
Nieto-Codesido, I., Calvo-Álvarez, U., Diego, C., Hammouri, Z. A. A., Mallah, N., Villamayor, M. J. G., Salgado, F. J., Carreira, J. M., Rábade, C., Barbeito, G., et al. (2022) · Open Respiratory Archives · doi:10.1016/j.opresp.2022.100162 · Cited by 9
Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19
Esa, T., Budu, B., Mulyono, B. E., Soraya, G. V., Usman, A. N., & Intansari, U. S. (2023) · F1000Research · doi:10.12688/f1000research.132157.1 · Cited by 7
The potential role of exosome on cytokine storm and treatment of severe COVID-19 infection
Kadriyan, H., Prasedya, E. S., Pieter, N. A. L., Gaffar, M., Punagi, A. Q., & Bukhari, A. (2020) · Bali Medical Journal · doi:10.15562/bmj.v9i3.1966 · Cited by 9
Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
Lü, J., Xie, Z., Zhu, D., & Li, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i7.1705 · Cited by 9
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management
Zhang, S., Wu, Y., Mprah, R., & Wang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1434331 · Cited by 8
Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction
Saha, A., Choudhary, S., Walia, P., Kumar, P., & Tomar, S. (2025) · Virology · doi:10.1016/j.virol.2025.110394 · Cited by 8
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Krivosova, M., Hanusrichterová, J., Lučanský, V., Samec, M., Bobčáková, A., Baranovičová, E., Dohál, M., Mokrý, J., Škereňová, M., Lipták, P., et al. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-024-00010-7 · Cited by 8
Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs
Howell, M., Green, R. J., McGill, A. R., Kahlil, R. M., Dutta, R., Mohapatra, S. S., & Mohapatra, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700705 · Cited by 8
Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients
Cavalcante, L. T. D. F., da Fonseca, G. C., Leon, L. A. A., Salvio, A. L., Brustolini, O. J. B., Gerber, A. L., Guimarães, A. P. D. C., Marques, C. A. B., Fernandes, R. A., Filho, C. H. F. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113588 · Cited by 8
Cytokine Kinetics during Progression of COVID-19 in Rwanda Patients: Could IL-9/IFNγ Ratio Predict Disease Severity?
Ndoricyimpaye, E. L., Snick, J. V., Robert, R., Bikorimana, E., Majyambere, O., Mukantwari, E., Nshimiyimana, T., Mbonigaba, V., Coutelier, J., & Rujeni, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512272 · Cited by 8
Role of IL-6 as ‘core inflammatory marker’ in assessment of severity, response to therapy and predicting outcome in COVID-19 pneumonia: A single center experience of 2400 cases in tertiary care setting in India
Patil, S. V., Patil, D., & Khule, S. (2024) · Sri Ramachandra Journal of Health Sciences · doi:10.25259/srjhs_17_2022 · Cited by 8
Treatment of the Cytokine Storm in COVID-19
Halaçlı, B., & Topeli̇, A. (2020) · Journal of Critical and Intensive Care · doi:10.37678/dcybd.2020.2434 · Cited by 9
Successful Treatment of a COVID-19 Case with Pneumonia and Renal Injury Using Tocilizumab
Ashino, Y., Yasutan, H. C., Hatta, M., Shirato, Y., Kyogoku, Y., Komuro, H., & Hattori, T. (2020) · Reports — Medical Cases Images and Videos · doi:10.3390/reports3040029 · Cited by 8
Immunomodulation and immunotherapeutics of COVID-19
Garg, S. S., Sharma, A., & Gupta, J. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108842 · Cited by 8
The effectiveness of dexamethasone as a combination therapy for COVID-19
Namazi, N. I. (2022) · Acta Pharmaceutica · doi:10.2478/acph-2022-0030 · Cited by 8
Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients
Mikačić, M., Kumrić, M., Baricevic, M., Tokić, D., Stipić, S. S., Cvitković, I., Šupe‐Domić, D., Kurir, T. T., & Božić, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133699 · Cited by 8
Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment
Chegni, H., Babaii, H., Hassan, Z. M., & Pourshaban, M. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221098970 · Cited by 8
The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes
Ranjbar, T., Oza, P. P., & Kashfi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213895 · Cited by 9
Role of Nutrition and Diet during COVID-19 pandemic: A narrative review
Pal, J., Sethi, D., Taywade, M., & Pal, R. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1311_21 · Cited by 8
Expression of SARS-CoV-2 receptor angiotensin-converting enzyme 2 by activating protein-1 in human mast cells
Kim, H., Kang, H., Kim, H., & Jeong, H. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104705 · Cited by 8
Antiviral optical techniques as a possible novel approach to COVID-19 treatment
Moshfegh, F., Khosraviani, F., Moghaddasi, N., Limoodi, S. F. S. J., & Boluki, E. (2021) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545821300020 · Cited by 8
Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19Preprint
Xi, W.-N., Jin, D., Sun, K., Yu, R.-Y., Yao, X., Zou, B.-S., Song, Z.-Y., Yang, A.-Y., Luo, R.-X., liu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.05.30.20117598 · Cited by 8
Implementation and findings on a one-minute sit-stand test for prehospital triage in patients with suspected COVID-19—a pilot project
Kjerulff, J. L., Bach, A., Væggemose, U., Skaarup, S. H., & Bøtker, M. T. (2022) · BMC Emergency Medicine · doi:10.1186/s12873-022-00605-9 · Cited by 7
Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases
Ghulam, U., Nazim, F., Farooqui, N., Rizwan-ul-Hasan, S., Anwar, M. F., Ahmed, K., Jamal, A., Kayani, H. A., Mughal, N., Hussain, A. R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279270 · Cited by 7
Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome
Deus, M. D. C., Gadotti, A. C., Dias, E. S., Alegre, J. B. M., Spitzenbergen, B. A. K. V., Bohnen, G., Tozoni, S. S., Stocco, R. B., Olandoski, M., Tuon, F. F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910578 · Cited by 7
High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.1 · Cited by 6
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)
Kwee, K. V., Murk, J., Yin, Q., Visch, M. B., Davidson, L., de Jong, E. M. G. J., van den Reek, J. M. P. A., & Tjioe, M. (2022) · Journal of Dermatological Treatment · doi:10.1080/09546634.2022.2161297 · Cited by 7
High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.3 · Cited by 11
St John’s wort (Hypericum perforatum L)
Coppock, R. W., & Dziwenka, M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00040-9 · Cited by 7
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications
Shawki, M. A., Elsayed, N. S., Mantawy, E. M., & Said, R. S. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1931302 · Cited by 7
U-shaped-aggressiveness of SARS-CoV-2: Period between initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study
Morgenstern‐Kaplan, D., Buitano-Tang, B., Gil, M. M., Pavón, A. Z.-P., & Talavera, J. O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243268 · Cited by 7
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome
Segú-Vergés, C., Artigas, L., Coma, M., & Peck, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280677 · Cited by 6
Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort study
Sezer, Ö., Nursal, A. F., Günal, Ö., Görgün, S., Tekcan, A., Ünlügüzel, G., & Yığıt, S. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2263490 · Cited by 6
Beyond the Pandemic: The Interplay and Biological Effects of COVID-19 on Cancer Patients -A Mini Review
Mijwil, M. M., Al-Mistarehi, A.-H. W., Alaabdin, A. M. Z., Ike, M. E., Mensah, G., & Addy, A. (2023) · Al-Salam Journal for Medical Science · doi:10.55145/ajbms.2024.03.01.005 · Cited by 7
Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID
Aadil, K. R., Bhange, K., Mishra, G., Sahu, A., Sharma, S., Pandey, N., Mishra, Y. K., Kaushik, A. K., & Kumar, R. (2025) · BioNanoScience · doi:10.1007/s12668-025-01812-x · Cited by 7
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge
Shen, Y., Ba, Y., Hu, Y., Wang, L., & Li, W. (2021) · Inflammation Research · doi:10.1007/s00011-020-01429-8 · Cited by 6
Additional Evidence for Commonalities between COVID-19 and Radiation Injury: Novel Insight into COVID-19 Candidate Drugs
Geng, F., Chen, J., Tang, S., Azzam, E. I., Zhang, J., & Zhang, S. (2022) · Radiation Research · doi:10.1667/rade-22-00058.1 · Cited by 6
Self-citation
Metabolic risks and prognosis of COVID-19: are dietary patterns important?
Bakırhan, H., Arpa, F. Ö., Uğur, H., Pehlivan, M., Saleki, N., & Çelik, T. (2022) · Nutrition & Food Science · doi:10.1108/nfs-10-2022-0360 · Cited by 6
Correlation of vitamin D levels with serum parameters in Covid-19 patients
Beheshti, M., Neisi, N., Parsanahad, M., Rasti, M., Nashibi, R., & Cheraghian, B. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.04.012 · Cited by 6
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
Chavda, V. P., Raval, N., Sheta, S., Vora, L. K., Elrashdy, F., Redwan, E. M. M. M., Uversky, V. N., & Ertaş, Y. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1064459 · Cited by 6
Cytokine response and damages in the lungs of aging Syrian hamsters on a high-fat diet infected with the SARS-CoV-2 virus
Fomin, G., Tabynov, K., Islamov, R., Turebekov, N. A., Yessimseit, D. T., & Yerubaev, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223086 · Cited by 6
COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
Pourazizi, M., Hakamifard, A., Peyman‎, A., Mohammadi, R., Dehghani, S., Tavousi, N., Hosseini, N., Tehrani, H. A., & Abtahi‐Naeini, B. (2023) · Parasite Immunology · doi:10.1111/pim.13016 · Cited by 6
Th-1, Th-2, Th-9, Th-17, Th-22 type cytokine concentrations of critical COVID-19 patients after treatment with Remdesivir
Kalantar, K., Talepoor, A. G., Vakili, M. E., Karami, N., Kalani, M., Ghandehari, F., Kabelitz, D., Meri, S., & Moattari, A. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152378 · Cited by 6
Cytokine storm syndrome in SARS-CoV-2: a review
Wahid, B., Rani, N., & Idrees, M. (2021) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2021-0062 · Cited by 6
The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury
Barbosa, N. C., Cristina‐Rodrigues, F., Temerozo, J. R., Souza, T. M. L., Gouvêa, A. L., Canetti, C. D. A., Kurtenbach, E., Bou‐Habib, D. C., Benjamim, C. F., Takiya, C. M., et al. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10062-7 · Cited by 5
Vitamina D y la pandemia por COVID-19
García-Contreras, A. I., & Álvarez-López, J. A. (2020) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000036 · Cited by 4
A Review on Modern Use of Intranasal Vaccination in the Treatment of SARS-COV-2
Shah, S. S., Patel, C. M., Patel, D. H., Vadgama, P. H., Patel, M. S., & Trivedi, R. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i4-s.4942 · Cited by 5
Clinical characterization of hospitalized COVID-19 patients during the second wave of pandemic in the district of Rohrbach, Upper Austria
Rosenberger, K., Pöschl, F., Geschev, S., Steiner, K., Puig, S., Roeper-Kelmayr, J., & Aichberger, K. J. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01961-5 · Cited by 5
Therapeutic Efficacy of Polyherbal Formulation Kabasura kudineer Against Common Viral Fevers - A Perspective Review
Kabilan, S. J., Kunjiappan, S., Sundaresan, H., Mahesh, S., & Srinivasan, G. (2022) · Anti-Infective Agents · doi:10.2174/2211352520666220527102858 · Cited by 5
Neuro–Immune Interactions in Severe COVID-19 Infection
Rossi, E. G., Mutti, L., Morrione, A., & Giordano, A. (2022) · Pathogens · doi:10.3390/pathogens11111256 · Cited by 7
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
El‐Tanani, M., Ahmed, K. A., Shakya, A. K., Ammari, W. G., & Al-Shudifat, A.-E. (2023) · Pharmaceuticals · doi:10.3390/ph16060799 · Cited by 4
SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic
Ahmed, W., Jia, F., Zhang, Y., & Chen, L. (2023) · Microorganisms · doi:10.3390/microorganisms11102511 · Cited by 5
Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model
Han, H., Kim, J.-E., & Lee, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-65447-w · Cited by 6
JNK kinase promotes inflammatory responses by inducing the expression of the inflammatory amplifier TREM1 during influenza a virus infection
Chen, N., Jin, J., Qiao, B., Gao, Z., Tian, Y., & Ping, J. (2025) · Virus Research · doi:10.1016/j.virusres.2025.199577 · Cited by 5

Authors: Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., Wang, J., & Wang, A.
Affiliations: Chinese People's Liberation Army (CN)
Nanjing University of Chinese Medicine (CN)
Jiangsu Province Hospital (CN)
Nanjing Drum Tower Hospital (CN)
Corresponding author: Wang, Jing
Wang, Aiping
ORCID: Wang, Tianyuan
Wei, Hongxia
Zhang, Zhihong
Wang, Jing
Wang, Aiping
Venue: Cytokine & Growth Factor Reviews
Publisher: Elsevier BV
Published: 2020-06
Volume: 53
Pages: 38-42
ISSN: 1359-6101 (ISSN-L)
DOI: 10.1016/j.cytogfr.2020.04.002
PMC: PMC7182527
OpenAlex: W3019663170
Cited by: 513
References: 36
Citations by year: 2026: 9 · 2025: 23 · 2024: 32 · 2023: 77 · 2022: 110 · 2021: 160 · 2020: 102
FWCI: 5.30
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Cytokine & Growth Factor Reviews (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords: cytokine storm, COVID-19 pandemic, SARS-CoV-2, COVID-19 pneumonia, cytokine monitoring, multiple organ failure, immune dysregulation, cytokine production, mortality, SARS, MERS, influenza, antiviral therapy
MeSH terms: Betacoronavirus, Continuous Renal Replacement Therapy, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Adrenal Cortex Hormones, Antibodies, Monoclonal, Female, Humans, Male, Multiple Organ Failure, Pneumonia, Viral, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Cytokines, Interferon-alpha, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks